<DOC>
	<DOCNO>NCT01406119</DOCNO>
	<brief_summary>This extension study ABT-806 subject advance solid tumor .</brief_summary>
	<brief_title>An Extension Study ABT-806 Subjects With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Subject complete prior study utilize ABT806 111ln ABT806 ( ABT 806i ) Investigator believe continued treatment ABT806 best interest subject . Women childbearing potential men must agree use adequate contraception ( one follow list ) prior study entry , duration study participation period 3 month . Female subject consider childbearing potential must document surgically sterile postmenopausal least 1 year . Subject capable understanding comply parameter outline protocol subject subject 's legal acceptable representative able sign inform consent , approve Institutional Review Board ( IRB ) prior initiation studyspecific procedure . Subject discontinue ABT806 or111ln ABT806 ( ABT806i ) administration complete prior study ( due disease progression , toxicity , withdrawn consent , ) . Subject medical condition opinion investigator place subject unacceptably high risk toxicity . Subject lactate pregnant female .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>